Skip to content

Vaxcel 45215Recalls & reported problems

Navilyst Medical, Inc. · Vaxcel Titanium Mini Port with PASV Valve Technology and 8F x 63cm Polyurethane Catheter · Class 2 · Implant

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
3
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI M001452150), received between Nov 17, 2025 and Mar 10, 2026 — classified as 1 injury, 2 malfunctions.

The most frequently reported specific device problem is “Fracture” (2 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 1 reportsDec 2025: 0 reportsJan 2026: 1 reportsFeb 2026: 0 reportsMar 2026: 1 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Fracture2
  • Adverse Event Without Identified Device or Use Problem1
  • Detachment of Device or Device Component1

Patient problems

  • Bacterial Infection1
  • Foreign Body In Patient1
  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

  • MalfunctionMar 10, 2026Fracture

    ON OR ABOUT (B)(6) 2012, PLAINTIFF UNDERWENT PLACEMENT OF AN ANGIODYNAMICS VAXCEL PORT PRODUCT, REFERENCE NUMBER (B)(4), LOT NUMBER 1333308. THE DEVICE WAS IMPLANTED AT SONY MONTGOMERY VA MEDICAL CENTER IN JACKSON, MISSISSIPPI FOR THE PURPOSE OF CHEMOTHERAPY. ON OR ABOUT (B)(6) 2021, PLAINTIFF PORT WAS NOTED TO BE FRACTURED, AND PORT REMOVAL WAS RECOMMENDED. ON OR ABOUT (B)(6) 2021, PLAINTIFF'S PORT WAS REMOVED BY DR. (B)(6) MD AT (B)(6) MEDICAL CENTER IN (B)(6).

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 24565601 ↗
  • InjuryJan 19, 2026Adverse Event Without Identified Device or Use Problem

    ON OR ABOUT (B)(6) 2012, PLAINTIFF UNDERWENT PLACEMENT OF A NAVILYST VAXCEL PORT CATHETER PRODUCT, WITH MODEL M001452150, AND LOT NUMBER 4415165.4 THE VAXCEL PORT IS COMPRISED OF A PORT BODY AND A POLYURETHANE CATHETER. THE DEVICE WAS IMPLANTED BY DR. (B)(6), M.D, (B)(6), FOR TREATING PLAINTIFF'S LUPUS. ON OR ABOUT (B)(6) 2016, PLAINTIFF PRESENTED TO (B)(6), WITH SYMPTOMS OF AN INFECTION. BLOOD DRAWN FROM PLAINTIFF'S PORT WAS CULTURED, AND CAME BACK POSITIVE FOR STAPHYLOCOCCUS HOMINIS, REQUIRING REMOVAL OF THE VAXCEL PORT. ON OR ABOUT (B)(6) 2016, PLAINTIFF UNDERWENT REMOVAL OF THE VAXCEL, AND THE PROCEDURE WAS PERFORMED BY DR. (B)(6), M.D. (B)(6).

    Patient problems: Bacterial Infection

    MAUDE report 24110430 ↗
  • MalfunctionNov 17, 2025Fracture; Detachment of Device or Device Component; Fracture; Detachment of Device or Device Component

    ON OR ABOUT (B)(6) 2010, PLAINTIFF UNDERWENT PLACEMENT OF THE NAVILYST VAXCEL PORT, REFERENCE NUMBER 45-215, LOT NUMBER 1377315. THE DEVICE WAS IMPLANTED BY DR. (B)(6), MD, AT (B)(6), FOR THE PURPOSE OF ONGOING INTRAVENOUS MEDICATIONS, HYDRATION, AND BLOOD DRAWS. ON OR ABOUT (B)(6) 2018, PLAINTIFF PRESENTED HERSELF TO (B)(6) WHERE PLAINTIFF LEARNED THAT HER PORT WAS FRACTURED AND/OR MALFUNCTIONED. PLAINTIFF WAS MADE AWARE BY HER PHYSICIAN THAT THE PORT COULD NOT BE REMOVED. THE PORT REMAINS IN THE PLAINTIFF'S BODY. PLAINTIFF DID NOT DISCOVER THE HEIGHTENED RISK OF THE FRACTURE RELATED TO VAXCEL PORT DEFECTS UNTIL AROUND (B)(6) 2023, WHEN SHE SAW AN AD REGARDING THE ANGIODYNAMICS' DEFECTIVE PRODUCTS LITIGATION AND RETAINED THE (B)(6).

    Patient problems: Foreign Body In Patient

    MAUDE report 23568526 ↗

Other PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR devices

All PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page